GPRC5B promotes collagen production in myofibroblasts

Area of Science:

• Cell Biology
• Biochemistry
• Pathology

Background:

• Fibrosis involves excessive extracellular matrix (ECM) production by myofibroblasts, leading to tissue hardening and organ dysfunction.
• The precise molecular mechanisms governing ECM production in myofibroblasts remain largely unknown.
• Understanding these mechanisms is crucial for developing effective treatments for fibrotic conditions.

Purpose of the Study:

• To investigate the role of G protein-coupled receptor class C group 5 member B (GPRC5B) in cardiac and lung myofibroblasts.
• To elucidate the molecular pathways regulating GPRC5B expression and its impact on ECM production.

Main Methods:

• Real-time RT-PCR was used to quantify gene expression.
• siRNA-mediated knockdown was employed to reduce GPRC5B levels.
• Expression analysis was performed in mouse models of fibrosis.

Main Results:

• Gprc5b expression was significantly elevated in fibrotic tissues and consistently found in myofibroblasts of fibrotic hearts and lungs.
• GPRC5B expression correlated with and potentially depended on the actin-MRTF-SRF signaling pathway.
• Knockdown of GPRC5B led to a reduction in collagen gene expression in myofibroblasts.

Conclusions:

• GPRC5B plays a significant role in promoting collagen production within myofibroblasts.
• GPRC5B directly contributes to the development of tissue fibrosis.
• Targeting GPRC5B may represent a novel therapeutic strategy for managing fibrotic diseases.